Results
eNauka >
Results >
Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results
| Title: | Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results | Authors  : | Mistry, Pramod K; ...; Petakov, Milan S; ...; (broj, koautora 18) | Issue Date: | 2021 | Publication: | AMERICAN JOURNAL OF HEMATOLOGY | ISSN: | 0361-8609 American Journal of Hematology Search Idenfier |
Type: | Article | Collation: | vol. 96 br. 9 str. 1156-1165 | DOI: | 10.1002/ajh.26276 | WoS-ID: | 000671766100001 | Scopus-ID: | 2-s2.0-85109414235 | PMID: | 34161616 | PMCID: | PMC8457136 | URI: | https://enauka.gov.rs/handle/123456789/826867 | Project: | Sanofi GenzymeSanofi-AventisGenzyme Corporation | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21aM21a |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.